Nigeria to Receive Long-Acting HIV Prevention Drug by March 2026 – NACA Announces Major Breakthrough

 

BREAKING NEWS: Nigeria to Receive Long-Acting HIV Prevention Drug by March 2026 – NACA

Abuja, Nigeria – The National Agency for the Control of AIDS (NACA) has announced that Nigeria is set to receive a long-acting HIV prevention drug by March 2026, marking a major milestone in the country's fight against HIV/AIDS.

According to NACA, the new medication is expected to significantly improve HIV prevention efforts by offering longer-lasting protection compared to existing daily oral pre-exposure prophylaxis (PrEP) options.

What is the Long-Acting HIV Prevention Drug?

The long-acting HIV prevention drug is an injectable form of PrEP that provides protection against HIV infection for an extended period, reducing the need for daily pills. Health experts say this innovation could improve adherence and accessibility, especially among high-risk populations.

Unlike traditional daily tablets, the injectable medication may only require administration once every few months, making it more convenient and discreet.

Nigeria’s Commitment to Ending HIV/AIDS

NACA emphasized that the introduction of the long-acting HIV prevention drug aligns with Nigeria’s commitment to achieving global HIV targets and reducing new infections nationwide.

The agency also reaffirmed its partnership with international health organizations to ensure effective distribution, monitoring, and awareness campaigns once the drug arrives in the country.

Impact on Public Health

Public health stakeholders believe the new prevention method could play a crucial role in:

• Reducing new HIV infections across Nigeria
• Improving medication adherence rates
• Enhancing protection among vulnerable groups
• Supporting Nigeria’s 95-95-95 HIV targets

With Nigeria carrying one of the highest HIV burdens in sub-Saharan Africa, the arrival of the long-acting drug is seen as a game-changing intervention.

What Nigerians Should Expect

Health authorities are expected to roll out awareness campaigns ahead of the drug’s arrival. Distribution plans, eligibility criteria, and access points will likely be communicated by NACA and the Federal Ministry of Health.

More updates are expected in the coming weeks as preparations intensify.

Stay connected to MpNaijaTv for more breaking health and national updates.

---

Keywords: Nigeria HIV news 2026, NACA HIV drug update, long acting HIV injection Nigeria, HIV prevention breakthrough Nigeria, HIV PrEP Nigeria